Nuove applicazioni della medicina nucleare in ambito diagnostico (I parte)
Authors:
Open Access
- 1 June 2010
- journal article
- Published by PAGEPress Publications in Italian Journal of Medicine
- Vol. 4 (2) , 84-91
Abstract
Discussion The recent development of new radiopharmaceuticals and the growth of hybrid tomographic devices, such as SPECT/CT and PET/CT, now permits molecular imaging of biologic processes at the cellular level to improve both the diagnosis and treatment of many tumours.Keywords
This publication has 28 references indexed in Scilit:
- Positron Emission Tomography/Computed Tomography: The Current Technology and ApplicationsRadiologic Clinics of North America, 2009
- Multimodality imaging: an update on PET/CT technologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- COMBINED IMAGING MODALITIES: PET/CT AND SPECT/CTHealth Physics, 2008
- Positron Emission Tomography/Computed TomographySeminars in Nuclear Medicine, 2008
- Imaging and PET — PET/CTimagingJournal de Radiologie, 2008
- The role of hybrid SPECT-CT in oncology: current and emerging clinical applicationsClinical Radiology, 2008
- Imaging of Neuroendocrine TumorsSeminars in Nuclear Medicine, 2006
- Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Functional–Anatomical Image Fusion in Neuroendocrine TumorsCancer Biotherapy and Radiopharmaceuticals, 2004
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003